I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Open-label Study to Determine the Maximum Tolerated Dose of DSG3-CAART in Mucosal-dominant PV Patients (mPV)
Mucosal-dominant pemphigus vulgaris (mPV) is a B-cell mediated autoimmune disorder in which painful blisters are formed on the mucosal membrane, including the mouth, nose, throat, eyelids, anus, and genitals.
- 0 views
- 19 Feb, 2024
IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
It is potentially fatal and the average mortality of pemphigus vulgaris (PV) was 75% before the introduction of corticosteroids in the early 1950s. Traditionally, treatment of pemphigus included high dose systemic corticosteroids with or without adjuvant immunosuppressants.
enzyme-linked immunosorbent assay
rituximab
immunoglobulins
immunoglobulin
igiv
- 0 views
- 19 Feb, 2024